Vancomycin resistant <i>Staphylococcus aureus</i> infections: A review of case updating and clinical features.

The infection caused by methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) is a global threat to public health. Vancomycin remains one of the first-line drugs for the treatment of MRSA infections. However, <i>S</i>. <i>aureus</i> isolates with complete resistance to vancomycin have emerged in... View More